Related by context. All words. (Click for frequent words.) 75 vinca alkaloid 74 acyclovir Lauriad R 73 Dapagliflozin 73 5 HT3 antagonist 73 metaglidasen 73 vinorelbine tartrate 72 Annamycin 72 docetaxel Taxotere R 72 TBC# 72 orally administered inhibitor 72 Tesetaxel 71 receptor tyrosine kinase inhibitor 71 Panzem R NCD 71 PNP inhibitor 71 5 fluorouracil leucovorin 71 Amrubicin 71 ChronVac C R 71 targeted antifolate 71 GVAX ® 71 Phase #b/#a clinical 70 targeted radiotherapeutic 70 HuMax TAC 70 investigational humanized monoclonal antibody 70 mertansine 70 proteasome inhibitor 70 topical gel formulation 70 PDE4 inhibitor 70 PEGylated Fab fragment 70 Pertuzumab 70 PI3K/Akt pathway inhibitor 70 Zoraxel TM 70 liposomal formulation 70 Belimumab 70 PEGylated interferon 70 Elagolix 70 CYT# potent vascular disrupting 70 chimeric monoclonal antibody 70 generation purine nucleoside 70 Mipomersen 70 dasatinib Sprycel 70 MKC# MKC# PP 70 oncolytic virus therapies 69 investigational monoclonal antibody 69 MAGE A3 ASCI 69 sapacitabine CYC# 69 docetaxel Taxotere ® 69 Nanobody 69 Temsirolimus 69 Fludara ® 69 LymphoStat B belimumab 69 metastatic hormone refractory 69 orally bioavailable 69 Archexin 69 sodium glucose cotransporter 69 highly selective endothelin 69 OncoVEX GM CSF 69 oral proteasome inhibitor 69 IMA# 69 accumulate preferentially 69 Aganocide 69 Alfacell proprietary ribonuclease 69 antibody MAb 69 demethylation agents 69 IMiDs R 69 molecular imaging radiopharmaceutical 69 hormone LHRH antagonist 69 AEG# 69 IMiDs ® 69 novel VDA molecule 69 ALN PCS 69 BRIM2 69 platinum chemotherapeutic 69 Dasatinib 69 IAP inhibitors 69 nucleoside analog 69 Argatroban 69 treat refractory angina 69 YONDELIS 69 autologous cellular immunotherapy 69 LEUKINE 69 Methylnaltrexone 68 non nucleoside inhibitor 68 Omacetaxine 68 candidate deforolimus 68 ABL inhibitor 68 Cloretazine ® 68 Nexavar ® 68 evaluating T DM1 68 cilengitide 68 humanized anti 68 Gleevec resistant 68 Piperacillin 68 methylnaltrexone bromide 68 generation Hsp# inhibitor 68 investigational pan BCR 68 refractory chronic lymphocytic 68 Daclizumab 68 oxidative stress inducer 68 BCR ABL inhibitors 68 metastatic colorectal 68 Besivance 68 Aflibercept 68 Panzem R 68 Personalized Immunotherapy 68 rxRNA 68 Orally administered 68 histone deacetylase HDAC inhibitor 68 PDX pralatrexate 68 humanized monoclonal 68 phase IIb clinical 68 Allovectin 7 68 Zorbtive TM 68 oral prodrug 68 Hsp# Inhibitor 68 forodesine 68 HCD# [002] 68 OMP #R# 68 Genasense ® 68 Soliris eculizumab 68 GW# [003] 68 BCR ABL inhibitor 68 selective estrogen receptor modulator 68 small molecule glucokinase 68 thalidomide Thalomid 68 IL# PE#QQR 68 Vidaza R 68 erlotinib Tarceva ® 68 ADP receptor antagonist 68 Voreloxin 68 Onco TCS 68 candidates Azedra TM 68 Peginterferon alfa 2b 68 evaluating tivozanib 68 Sapacitabine 68 Troxatyl 68 dasatinib Sprycel ® 68 class anticancer quinolone 68 hypereosinophilic syndrome 68 ALN TTR# 68 alkylating agent 68 AAG geldanamycin analog 68 imatinib Gleevec ® 68 humanised monoclonal antibody 68 PSMA ADC 68 investigational integrase inhibitor 68 Azedra 68 active cellular immunotherapies 68 visilizumab 67 3 registrational trial 67 cetuximab Erbitux R 67 IgG1 monoclonal antibody 67 R sorafenib tablets 67 lipid nanoparticle 67 oral ghrelin agonist 67 therapeutic monoclonal antibody 67 epothilones 67 evaluating picoplatin 67 SPRYCEL ® 67 delivery polymer matrix 67 Elesclomol 67 PEG interferon 67 Factor VIIa 67 Vidaza azacitidine 67 Taxotere docetaxel 67 2 methoxyestradiol 67 Maribavir 67 regorafenib 67 peptibody 67 SCIB1 67 oral talactoferrin 67 BLyS specific 67 volociximab 67 somatostatin analogue 67 perifosine novel potentially 67 relapsed multiple myeloma 67 small molecule Hedgehog 67 bevacizumab Avastin ® 67 allogeneic cell 67 oncolytic vaccine 67 ELACYT 67 human IgG1 monoclonal 67 Squalamine 67 intranasal formulation 67 thymalfasin 67 Lenocta 67 protein tyrosine phosphatase 1B 67 Liposomal 67 vascular disrupting agent 67 Immune SIMULATORS 67 renin inhibitors 67 Atripla combines 67 alvespimycin 67 Pralatrexate 67 investigational pharmacologically unique 67 Xeloda capecitabine 67 epothilone 67 BYETTA ® 67 angiogenesis inhibitor 67 ZK EPO 67 multi kinase inhibitor 67 selective kinase inhibitor 67 Pemetrexed 67 Initiate Clinical Trial 67 PORxin TM platforms 67 evaluating satraplatin 67 lintuzumab SGN 67 antimetabolite 67 proteasome inhibitors 67 cediranib 67 humanized monoclonal antibody 67 oncolytic 67 candidates Azedra 67 assessing T DM1 67 luteinizing hormone releasing 67 Degarelix 67 HQK 67 Bosutinib 67 MKC# MT 67 transcriptase inhibitor NNRTI 67 paclitaxel Taxol 67 Quinamed 67 Ozarelix 67 LymphoStat B TM 67 Bucindolol 67 AKT inhibitor 67 HCV polymerase inhibitors 67 vapreotide acetate 67 Inhalation Aerosol 67 nucleotide analogue 67 product Fentanyl TAIFUN 67 VitiGam 67 pan HDAC inhibitor 67 HCV NS5B polymerase 67 inhaled formulation 67 PKC# 67 HuMax CD4 67 CD# antibody [001] 67 Gemzar ® 67 Traficet EN 67 microtubule inhibitor 67 oral nucleoside analogue 67 JAK inhibitor 67 targeting CD# 67 Pathway Inhibitor 67 bevacizumab Avastin 67 TOCOSOL Camptothecin 67 hypoxia activated prodrug 67 Taxol ® 67 Clolar ® 66 L Annamycin 66 Trastuzumab DM1 66 Zalypsis 66 anti angiogenic agent 66 reslizumab 66 Irinotecan 66 Vicriviroc 66 maturation inhibitor 66 trastuzumab DM1 T DM1 66 anticoagulant reversing agent 66 MEK inhibitors 66 neuro inflammatory 66 Topotecan 66 fludarabine phosphate 66 telomerase therapeutic 66 Pruvel TM 66 approved incretin mimetic 66 Xanafide 66 overactive bladder AA# 66 R Saizen R 66 Trabectedin 66 demonstrated antitumor activity 66 HGS# 66 seliciclib CYC# 66 humanized antibody 66 R bendamustine hydrochloride 66 LHRH antagonists 66 novel histone deacetylase 66 Erbitux cetuximab 66 antisense drug 66 corticosteroid dexamethasone 66 myelofibrosis polycythemia vera 66 acetonide FA 66 M# rationally 66 kidney urologic 66 Saizen R 66 JAK3 inhibitor 66 Albuferon TM 66 brand ciclesonide HFA 66 VEGFR2 inhibitor 66 OrCel ® 66 Sphingomab TM 66 generation antisense 66 Proxinium TM 66 topically applied SEPA 66 ZOLINZA 66 mTOR inhibitor 66 PEG SN# 66 CCX# 66 selective androgen receptor modulator 66 metastatic CRC 66 Onalta 66 receptor modulators 66 Lubiprostone 66 hyaluronidase enzyme 66 unresectable locally advanced 66 GV# [001] 66 Bezielle 66 biologic therapy 66 investigational immunotherapy 66 XYOTAX TM 66 CEQ# 66 Sym# 66 triggers apoptosis programmed 66 nilotinib Tasigna ® 66 topical antifungal 66 SinuNase TM 66 Humira adalimumab 66 IMPDH inhibitor 66 echinocandin 66 CCR9 antagonist 66 cutaneous T 66 oral dihydropyrimidine dehydrogenase DPD 66 IRX 2 66 cetuximab Erbitux ® 66 Genentech Rituxan 66 candidate TNFerade biologic 66 RhuDex ® 66 recurrent metastatic ovarian cancer 66 pan histone deacetylase 66 novel peptide 66 vascular disrupting agents 66 developing TB4 66 nucleoside reverse transcriptase inhibitor 66 vinca alkaloids 66 Achieves Primary Endpoint 66 pharmacologically active isomer 66 constipation OIC 66 HER2 positive metastatic breast 66 Onalta ™ 66 Xcellerated T Cells 66 peripherally acting 66 Alkeran 66 Ganciclovir 66 SAR# [004] 66 nucleoside analogue 66 Tarceva TM 66 Solazed TM 66 small molecule thrombopoietin 66 Elotuzumab 66 Luteinizing Hormone Releasing Hormone 66 selective orally bioavailable 66 Telatinib 66 Kit CD# positive 66 tyrosine kinase inhibitor TKI 66 Phase Ib study 66 personalized cellular immunotherapy 66 GRNVAC1 66 BrachySil 66 rALLy clinical trial 66 ixabepilone 66 cathepsin K inhibitor 66 Phase Ib II 66 liposomal delivery 66 relapsed MM 66 ENMD # 66 TLR9 agonist 66 relapsed leukemia 66 Bazedoxifene 66 Prodarsan R 66 lenalidomide Revlimid R 66 POTELLIGENT ® 66 IMiD 66 oral renin inhibitor 66 BAY #-# 66 Blinatumomab 66 CHOP chemotherapy 66 alefacept 66 OncoVEX 66 Dalbavancin 66 tumor vascular disrupting 66 including eniluracil ADH 66 Deforolimus 66 MKC# 66 CCR5 antagonist 66 sorafenib tablets 66 Letairis ambrisentan 66 subcutaneous formulation 66 acyclovir Lauriad ® 66 registrational trial 66 TRC# 66 INSPIRE Trial Phase III 66 nilotinib Tasigna 66 apomorphine hydrochloride 66 octreotide implant 66 Imatinib mesylate 66 Initiates Phase II 66 NXL# 66 AFREZZA TM 66 candidate AP# 66 ocular formulation 66 paclitaxel Taxol ® 66 ospemifene 66 Inhalation Solution 66 pegylated interferon alpha 66 intravenously administered 66 Fibrin Pad 66 HCV protease inhibitor 66 advanced metastatic renal 66 Romidepsin 66 IAP inhibitor 66 interferon gamma 1b 66 anticancer compound 66 oral rivaroxaban 66 ketolide antibiotic 66 NPC 1C 66 Liprotamase 66 bucindolol hydrochloride 66 OvaRex ® MAb 66 selective immunoproteasome inhibitor 66 Pivotal Phase III 66 DermaVir Patch 66 Pharmacokinetics PK 66 Chemophase 66 potent topoisomerase II 66 delta gamma agonist 66 Targretin capsules 66 Gemcitabine 65 IMiDs ® compound 65 multiple myeloma MM 65 Vicinium TM 65 sorafenib Nexavar 65 Enkephalin 65 polymerase inhibitor 65 inhalation powder 65 anti EGFR antibody 65 developing Bicifadine serotonin 65 pegfilgrastim 65 Ixempra 65 pertuzumab 65 fusion inhibitors 65 Empatic ™ 65 Altera Nebulizer System 65 LEVADEX ™ 65 peptidic compound 65 Bevacizumab 65 barrier gauze dressings 65 BiovaxID TM 65 Gamunex C 65 delivers fluocinolone acetonide FA 65 etanercept Enbrel 65 CYT# QbG# 65 motexafin gadolinium Injection 65 product candidate Lpathomab 65 multitargeted 65 nasal spray formulation 65 biologic antibody 65 intravesical infusion therapy 65 Vidofludimus 65 oral ridaforolimus 65 HSP# inhibitor 65 Oral NKTR 65 orally inhaled 65 Virulizin ® 65 agonistic human 65 recombinant subunit vaccine 65 nucleotide analog 65 CTA# Injection 65 Neuromodulation System 65 drug conjugate 65 hormone refractory metastatic prostate 65 refractory metastatic colorectal cancer 65 humanized therapeutic 65 signal transduction inhibitor 65 radezolid 65 OMNARIS HFA 65 BiTE R 65 ALVESCO ® 65 RNAi therapeutic targeting 65 recombinant adeno associated 65 HCV protease inhibitors 65 use transdermal sumatriptan 65 docetaxel chemotherapy 65 leading oral taxane 65 unique alkylating agent 65 dexamethasone Decadron 65 SERMs 65 Etoposide 65 PrevOnco ™ 65 xanthine oxidase inhibitor 65 Xyfid TM 65 Mg Usa 65 ONCASPAR 65 TNF Tumor Necrosis Factor 65 peptide conjugated 65 Myocet 65 ALN TTR 65 oral immunomodulatory 65 Ustekinumab 65 endothelin antagonist 65 Clevudine 65 Phase Ib IIa 65 ApoB SNALP 65 non porcine pancreatic 65 Novolimus 65 Intravenous Human 65 XL# anticancer compounds 65 HuMax EGFr 65 miconazole Lauriad ® 65 vemurafenib 65 lead molecular radiotherapeutic 65 galiximab 65 either acutely decompensated 65 Aztreonam 65 Meets Primary Endpoint 65 DUROS 65 Lenalidomide 65 Thiarabine 65 relapsed refractory multiple myeloma 65 Levoleucovorin 65 Onalta TM 65 CD4 monoclonal antibody 65 castrate resistant prostate cancer 65 candidate XP# 65 Talabostat 65 HepeX B TM 65 Genasense ® oblimersen 65 ATL# [001] 65 trabectedin 65 CTAP# Capsules 65 Tasigna nilotinib 65 Trastuzumab 65 Cloretazine VNP#M 65 ISENTRESS raltegravir 65 TELINTRA R 65 Ofatumumab 65 selective S#P# receptor agonist 65 Afatinib 65 DCVax R 65 PORxin TM 65 nanopharmaceutical 65 Alocrest 65 Oncaspar 65 INxin TM 65 OMP #M# 65 Navelbine ® 65 poly ADP ribose polymerase 65 Zolinza 65 VersaFilm 65 MOVIPREP R 65 toenail onychomycosis 65 Xeloda ® 65 lipoglycopeptide 65 melphalan prednisone 65 compound perifosine 65 oral antiviral 65 Bavituximab 65 histone deacetylase HDAC inhibitors 65 prostate cancer HRPC 65 Hycamtin 65 Ixabepilone 65 Inhaled nitric oxide 65 Completes Patient Enrollment 65 paclitaxel poliglumex 65 Aplidin 65 immunomodulator 65 VALSTAR 65 ACIs 65 fluocinolone acetonide 65 Fc fusion protein 65 refractory cutaneous T 65 BiTE 65 immune modulator 65 vaccines oncolytic virus 65 rilonacept Injection 65 huC# DM4 65 Copegus ribavirin 65 VISICOL R 65 MVA BN R 65 Laquinimod 65 DiLA2 65 histone deacetylase HDAC 65 MT#/MEDI-# 65 purine analog 65 Imprime PGG 65 bortezomib Velcade 65 octreotide acetate 65 Fludarabine 65 candidate ridaforolimus 65 novel topoisomerase 65 topical ophthalmic 65 SPL# Gel vaginal microbicide 65 Civacir 65 mild vasodilator 65 idarubicin 65 HDAC Inhibitor 65 ceftazidime 65 Seliciclib 65 HIV integrase inhibitors 65 ara C 65 deforolimus 65 FS Antihemophilic Factor Recombinant 65 leukemia AML 65 novel nucleoside analog 65 Aliskiren 65 initiated Phase Ib 65 pegylated interferons 65 Lixisenatide 65 demethylating agent 65 PROVENGE sipuleucel T 65 Gleevec imatinib mesylate 65 FOLOTYN ® 65 PHX# 65 Provectus Pharmaceuticals specializes 65 Angiocept 65 Pruvel ™ 65 Linaclotide 65 Advanced Renal Cell 65 Temodar ® 65 Solazed ™ 65 melanocortin receptor agonists 64 Ranibizumab 64 humanised antibody 64 cetuximab Erbitux 64 PRN FDA Approves 64 direct renin inhibitor 64 novel oral anticoagulant 64 3TC lamivudine 64 Resten NG 64 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 64 Tofacitinib 64 candidate Zemiva 64 Carfilzomib 64 tubulin inhibitors 64 vidofludimus 64 blinded randomized placebo controlled 64 alkylating 64 Adnectin 64 DEB# 64 Glufosfamide 64 Epratuzumab 64 mRCC 64 Smac mimetics 64 Somatuline Depot 64 Velcade bortezomib 64 Iluvien ® 64 Nilotinib 64 Actimmune ® 64 small molecule tyrosine 64 Clofarabine 64 A1PI 64 adalimumab Humira 64 Solazed 64 Delafloxacin 64 treat male hypogonadism 64 peptidomimetic 64 interferon beta 1b 64 SPC# [001] 64 Company proprietary Biochronomer 64 TELINTRA 64 Tibotec Therapeutics division 64 Aryplase 64 Saquinavir 64 diarrhea predominant irritable 64 therapeutic peptide 64 TACI Ig 64 KNS # 64 Chemokine Receptor 64 radiation sensitizer 64 FOLFOX6 chemotherapy regimen 64 albiglutide 64 Kuvan sapropterin dihydrochloride 64 Hycamtin ® 64 metastatic HRPC 64 gemcitabine Gemzar 64 NVA# 64 muscarinic receptor agonist 64 Icatibant 64 Syncria 64 Mg Uk 64 Ophena TM 64 Elvitegravir 64 mGluR5 negative 64 OHR/AVR# 64 MYDICAR ® 64 nucleoside polymerase inhibitor 64 Silodosin 64 ZACTIMA 64 riociguat 64 mda 7 64 pancreatic enzyme replacement 64 administered intranasally 64 long acting muscarinic 64 bispecific 64 cancer immunotherapies 64 Cx# [002] 64 orally disintegrating 64 pegylated 64 taxane derivative 64 Roflumilast 64 cephalosporin antibiotic 64 elotuzumab 64 BiTE ® 64 candidate Zenvia 64 antiinfectives called 64 oral transmucosal 64 Taxanes 64 Selective Electrochemical Tumor Ablation 64 BRAF inhibitor 64 Abiraterone acetate 64 bortezomib Velcade R 64 generation cephalosporin 64 CINQUIL 64 metastatic castrate resistant 64 Currently RegeneRx 64 hormone agonist 64 Intravenous CP 64 Eniluracil 64 pseudobulbar affect PBA 64 R#/MEM # 64 Sutent sunitinib 64 Actemra tocilizumab 64 Maraviroc 64 HepaMate 64 systemic RNAi therapeutic 64 NanoTab 64 tubulin inhibitor 64 glioblastoma multiforme GBM 64 Ostabolin C TM 64 inhibits angiogenesis 64 Ovitrelle R Serostim 64 elacytarabine 64 Tykerb lapatinib 64 Oxaliplatin 64 Aviptadil 64 Fingolimod 64 Eraxis 64 Empatic TM 64 Pirfenidone 64 RECOTHROM R 64 TRAIL receptor antibodies 64 fusion inhibitor 64 UPLYSO 64 bendamustine ifosfamide 64 miconazole Lauriad R 64 MEK Inhibitor 64 IMC A# 64 BiTE antibodies represent 64 CD3 monoclonal antibody 64 IV acetaminophen 64 torezolid phosphate 64 anionic backbone 64 cell carcinoma RCC 64 muco adhesive technology 64 sufentanil 64 Palonosetron 64 thetreatment 64 modified glutathione analog 64 highly purified pasteurized 64 HGS ETR2 64 Tasimelteon 64 eosinophilic asthma 64 candidate Zemiva TM 64 XL# XL# 64 oral Janus kinase 64 M2 subunit 64 PGL# 64 anti CD# antibodies 64 Proquin XR 64 PEGylated anti 64 allosteric modulator NAM 64 PLK1 SNALP 64 Tanespimycin 64 StemEx 64 VANOS TM 64 LHRH receptor positive 64 Cefazolin 64 gastrointestinal stromal tumors GIST 64 Bremelanotide 64 trastuzumab Herceptin R 64 lapatinib Tykerb 64 TRO# 64 progressive metastatic prostate 64 rusalatide acetate 64 PANVAC VF 64 Antigenics QS 64 urethral bulking agent 64 HyperAcute 64 Saxagliptin 64 systemic anaplastic large 64 SUPPRELIN R LA 64 Factor Receptor 64 Angiotensin Converting Enzyme 64 subcutaneously administered 64 XYNTHA 64 Adjuvant Treatment 64 Omnitarg 64 Known generically 64 Brentuximab vedotin 64 TREANDA 64 virus HCV protease inhibitor 64 refractory NSCLC 64 Enhanze Technology 64 Jevtana 64 gemcitabine Gemzar ® 64 IgG1 antibody 64 paclitaxel Taxol R 64 XOMA 3AB 64 HCl Tablets 64 PERLANE 64 selective modulator 64 SinuNase ™ 64 hPTH #-# 64 fluoroquinolone class 64 Pfizer Camptosar 64 Curaxin CBLC# 64 BCG refractory carcinoma 64 Bayer HealthCare Onyx Pharmaceuticals 64 Evoltra ® 64 DB# [003] 64 iobenguane 64 Combination REOLYSIN R 64 anticancer agent 64 Abstral ® 64 MEK inhibitor 64 Lixivaptan 64 siRNA binds 64 HepaSphere 64 selective serotonin 2C receptor 64 direct thrombin inhibitor 64 non peptidic protease 64 immunotherapeutic vaccine 64 RELISTOR ® 64 Triapine 64 generation PNP inhibitor 64 Vandetanib 64 Interferon alpha 64 Ceflatonin 64 Mepact 64 TÎ ² 4 64 nasal calcitonin product 64 INT# [002] 64 taxane 64 oral dual endothelin 64 5 FU leucovorin 64 Campath alemtuzumab 64 Serdaxin ® 64 First Patient Dosed 64 TLK# 64 familial amyloidotic polyneuropathy FAP 64 Safinamide 64 Oracea TM 64 pralatrexate injection folate analogue 64 HepaGam B 64 Aurora kinase inhibitor 64 Tezampanel 64 BENLYSTA ® 64 Sanofi Pasteur Fluzone 64 novel synthetic peptide 64 Tamibarotene 64 BrachySil TM 64 doxercalciferol 64 HuLuc# 64 PEGylated 64 aflibercept VEGF Trap 64 immune modulators 64 Micromet BiTE 64 Xelox 64 non thiazolidinedione TZD 64 beta lactamase inhibitor 64 Ceflatonin R 64 Curaxin 64 cell lymphoma CTCL 64 Campath ® 64 essential thrombocythemia ET 64 nalbuphine ER 64 Ciclesonide 64 stable nucleic acid 64 Onconase 64 oral Hsp# inhibitor 64 hA# 64 proprietary polysaccharide 64 Nanobody ® 64 chemotherapeutic drug 64 iloprost synthetic compound 64 MGd 64 ofatumumab HuMax CD# 64 Vascular Wrap TM 64 pediatric acute lymphoblastic 64 Epothilone D 64 huN# DM1 64 personalized dendritic cell 64 metformin XR 64 imatinib Gleevec 64 #I TM# 64 arsenic trioxide injection 64 Monoclonal antibody 64 LNPs 64 Neupogen ® 64 Fodosine 64 TRX1 64 Gleevec imatinib 64 BEMA TM Fentanyl 64 PD LID 64 rhIGF-I/rhIGFBP-3 64 EGS# 64 synthetic peptide 63 Phase Ib clinical trials 63 transdermal spray 63 Melphalan 63 clinical trials Archexin 63 Provenge sipuleucel T 63 therapeutically inactive prodrug 63 drug eluting coronary stent 63 TNF alpha inhibitor 63 Roche Boniva 63 darinaparsin ZIO 63 neratinib 63 Cyclosert 63 Ridaforolimus 63 NeuroSTAT ® 63 Genasense oblimersen sodium Injection 63 tiuxetan 63 trans retinoic acid ATRA 63 depsipeptide 63 LHRH antagonist 63 Indomethacin 63 anti TNF alpha 63 Anti VEGF 63 DU #b 63 SCCHN 63 Xcytrin R 63 QuadraSphere 63 efaproxiral 63 RNAi Therapeutic 63 BeneFIX 63 Oral Spray 63 INS# [001] 63 CDK inhibitor 63 Fluorouracil 63 sublingual tablet formulation 63 small molecule chemotherapeutic 63 IV Busulfex 63 ALGRX 63 Cloretazine R 63 Cleviprex TM clevidipine 63 candidate REP# 63 candidate DB# 63 Vitrasert R 63 IMC #B 63 ORENCIA ® 63 CIMZIA ™ 63 incretin mimetic 63 Golimumab 63 liposomal doxorubicin 63 Preclinical studies suggest 63 Pazopanib 63 drug zotarolimus 63 antimitotic 63 Auxilium transmucosal film 63 Initiates Enrollment 63 Initiate Phase 63 Panzem NCD 63 Epirubicin 63 Vidaza ® 63 MT# MEDI 63 Cetrorelix 63 JAK2 inhibitor 63 inhibitor PPI 63 orally bioavailable mimics 63 insulin sensitizers 63 Vernakalant 63 IMiDs 63 Pegasys ® 63 AERx ® 63 CCR5 receptor antagonist 63 Systemic Delivery 63 Zarnestra 63 immunotoxin 63 treat lupus renal 63 HeartMate ® 63 Interferon beta 63 metastatic colorectal carcinoma 63 tanespimycin 63 chemotherapeutic regimen 63 OncoGel 63 Naproxcinod 63 Herceptin trastuzumab 63 Granisetron 63 Janus Kinase 63 Gleevec Glivec 63 atrial fibrillation budiodarone ATI 63 chemotherapy cisplatin 63 tazarotene 63 antiangiogenesis therapies 63 androgen receptor antagonist 63 OrCel R 63 ChronVac C ® 63 DOS# 63 lexidronam injection